A study of clinical spectrum of opportunistic infections in HIV infected children and its correlation with CD4 count and anti-retroviral therapy

Authors

  • Vishal Manohar Jadhav Department of Pediatrics, LTMMC and LTMGH, Sion, Mumbai, Maharashtra, India
  • Yashwant Raghu Gabhale Department of Pediatrics, LTMMC and LTMGH, Sion, Mumbai, Maharashtra, India
  • Mamatha Murad Lala Department of Pediatrics, LTMMC and LTMGH, Sion, Mumbai, Maharashtra, India
  • Nikita Dilip Shah Department of Pediatrics, LTMMC and LTMGH, Sion, Mumbai, Maharashtra, India
  • Mamta Vijay Manglani Department of Pediatrics, LTMMC and LTMGH, Sion, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20172691

Keywords:

Anti-retroviral treatment, CD4 count, HIV, Opportunistic infections, Tuberculosis

Abstract

Background: To determine the clinical spectrum and prevalence of opportunistic infections (OIs) in HIV infected children and correlate the occurrence of opportunistic infections with their CD4 count and Anti-retroviral treatment (ART).

Methods: A total of 100 HIV infected children diagnosed with opportunistic infections were included in the study. Demographic details, clinical examination and relevant investigations were done for all the children. Clinical spectrum of OIs and HIV staging was recorded. CD4 counts were done at baseline and were repeated at 6 monthly intervals.

Results: Mean age of the patients was 7.08±3.48 years (ranging from 6 months to 15 years) at enrollment with male to female ratio of 1.2:1. Fever (91%) was a common presenting symptom followed by weight loss (74%), cough (37%), abdominal pain (29%) and breathlessness (16%). CD4 count was significantly associated with presence of opportunistic infection in the study group. Tuberculosis - pulmonary (32%) and extra-pulmonary (29%) was the most common oppurtunistic infections, followed by oral thrush (13%), Herpes zoster (10%), Molluscum Contagiosum (9%), Pneumocystis jiroveci pneumonia (3%), Parvovirus infection (3%) and Pruritic Papular Eruptions (2%). 70% children were on ART as per clinical and immunological staging of HIV.

Conclusions: Low CD4 count is significantly associated with severe opportunistic infections, therefore drop in CD4 count should serve as an alarming signal for the treating physician. High index of suspicion is required to detect opportunistic infections and therefore CD4 counts should be done more frequently to predict occurrence of OIs. 

References

UNICEF 2016. Global and Regional Trends. Available at: https://data.unicef.org/topic/hivaids/global-regional-trends/.

UNAIDS 2013 global report: UNAIDS report on the global AIDS epidemic 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013.

Haynes BF, Pantaleo G, Fauci AS. Towards an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271:324-8.

Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol. 1996;50:825-54.

CDC Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Recommendations and Reports 58; 2009.

Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on survival in patients with HIV infection. AIDS. 1998;12:29-33.

Chaisson RE, Moore RD. Prevention of opportunistic infections in the era of improved antiretroviral therapy. J Acquir Immune Deficiency Syndrome Hum Retrovirol. 1997;16:14-22.

Sehgal R, Baveja UK, Chattopadhya D, Chandra J and Lal S. Pediatric HIV infection. Indian J Pediatr. 2005;72(11):925-30.

Ferrand RA, Desai SR, Hopkins C, Elston CM, Copley SJ, Nathoo K, et al. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis. 2012;55(1):145-52.

Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364: 1865-71.

Alarcon JO, Hance LF, Krauss M, Reyes MF. Opportunistic and Other Infections in HIV-Infected Children in Latin America Compared to a Similar Cohort in the United States. AIDS Research and Human Retrovirus. 2012;28(3):282-8.

Madhivanan P, Mothi SN, Kumarasamy N, Yepthomi T, Venkatesan C, Lambert JS, Solomon S. Clinical manifestations of HIV infected children. Indian J Pediatr. 2003;70(8):615-20.

Shah SR, Tullu MS, Kamat JR. Clinical profile of pediatric HIV infection from India. Arch Med Res. 2005;36(1):24-31.

Rajasekaran S, Jeyaseelan L, Raja K, Ravichandran N. Demographic and clinical profile of HIV infected children accessing care at Tambaram, Chennai, India. Indian J Med Res. 2009;129:42-9.

Panya MF, Mgonda YM, Massawe AW. The pattern of mucocutaneous disorders in HIV-infected children attending care and treatment centers in Dar es Salaam, Tanzania. BMC Public Health. 2009;9:234.

Prabhavathi R, Basavaraj, Veera Shankar M, Taru Sharma, Bhavya, Vinodchandran, Remya and Sreekantha. Clinical Spectrum of Presentation in HIV Infected Children with Correlation to CD4 Percentage. Rese J Pharmaceut, Biol Chemic Sci. 2013;4:395-402.

Agarwal D, Chakravarty J, Sundar S, Gupta V and Bhatia BD. Correlation between Clinical Features and Degree of Immunosuppression in HIV Infected Children. Indian paediatrics. 2008;45:140-3.

Candiani TMS, Pinto J, Cardoso CAA, Carvalho IR, Dias ACM, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. Cad. Saúde Pública, Rio de Janeiro. 2007;23(3):414-23.

De Santis GC, Brunetta DM, Vilar FC, Brandão RA, de Albernaz Muniz RZ. Hematological abnormalities in HIV-infected patients. Int J Infect Dis. 2011;15(12):808-11.

Babadoko AA, Aminu SM, Suleiman AN. Neutropenia and human immunodeficiency virus-1 infection: analysis of 43 cases. Niger J Med. 2008;17(1):57-60.

Salmen S, Montes H, Soyano A, Hernández D, Berrueta L. Mechanisms of neutrophil death in human immunodeficiency virus-infected patients: role of reactive oxygen species, caspases and map kinase pathways. Clin Exp Immunol. 2007;150(3):539-45.

Yadav J, Nanda S, Sharma D. Opportunistic Infections and Complications in Human Immunodeficiency Virus-1-Infected Children. Sultan Qaboos University Med J. 2014;14(4):13-21.

Shafer RW. Tuberculosis. In: Broder S, Merigan TC Jr, Bolognesi D, editors. Textbook of AIDS medicine. 2nd ed. Baltimore: Williams and Wilkins. 1994:259-282.

Gona P, Dyke RBV, Williams PL, Dankner WM. Incidence of Opportunistic and Other Infections in HIV-Infected Children in the Haart Era. JAMA. 2006;296(3):292-300.

Downloads

Published

2017-06-21

Issue

Section

Original Research Articles